FLUARIX TETRA inactivated split influenza vaccine suspension for injection 0.5 mL pre-filled syringe without needle, SH2024 influenza season Australië - Engels - Department of Health (Therapeutic Goods Administration)

fluarix tetra inactivated split influenza vaccine suspension for injection 0.5 ml pre-filled syringe without needle, sh2024 influenza season

glaxosmithkline australia pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: dl-alpha-tocopheryl acid succinate; potassium chloride; sodium chloride; water for injections; polysorbate 80; dibasic sodium phosphate dodecahydrate; magnesium chloride hexahydrate; octoxinol 10; monobasic potassium phosphate - fluarix tetra is a quadrivalent vaccine indicated for active immunisation of adults and children from 6 months of age for the prevention of influenza disease caused by the influenza virus types a and b contained in the vaccine (see section 5.1 pharmacodynamic properties, clinical trials).,the use of fluarix tetra should be based on official recommendations.

INFLUENZA A (H1N1) 2009 PANDEMIC MONOVALENT VACCINE (WITHOUT ADJUVANT) SUSPENSION Canada - Engels - Health Canada

influenza a (h1n1) 2009 pandemic monovalent vaccine (without adjuvant) suspension

id biomedical corporation of quebec - haemagglutinin from a/california/7/2009 (h1n1)v-like strain (x-179a) - suspension - 15mcg - haemagglutinin from a/california/7/2009 (h1n1)v-like strain (x-179a) 15mcg - vaccines

PANVAX H1N1 VACCINE JUNIOR H1N1 pandemic influenza vaccine (split-virion, inactivated) 0.25mL suspension for injection pre-filled syringe Australië - Engels - Department of Health (Therapeutic Goods Administration)

panvax h1n1 vaccine junior h1n1 pandemic influenza vaccine (split-virion, inactivated) 0.25ml suspension for injection pre-filled syringe

seqirus pty ltd - influenza virus haemagglutinin, quantity: 7.5 microgram - injection, suspension - excipient ingredients: sodium chloride; dibasic sodium phosphate; monobasic sodium phosphate; potassium chloride; monobasic potassium phosphate; calcium chloride dihydrate - for active immunisation to prevent influenza disease caused by the influenza a (h1n1) virus, in persons from 6 months of age.

PANVAX H1N1 VACCINE, H1N1 pandemic influenza vaccine (split-virion, inactivated) 5mL multi-dose injection vial Australië - Engels - Department of Health (Therapeutic Goods Administration)

panvax h1n1 vaccine, h1n1 pandemic influenza vaccine (split-virion, inactivated) 5ml multi-dose injection vial

seqirus pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: sodium chloride; dibasic sodium phosphate; monobasic sodium phosphate; potassium chloride; monobasic potassium phosphate; calcium chloride dihydrate; thiomersal - for active immunisation to prevent influenza disease caused by the influenza a (h1n1) virus, in persons from 6 months of age.

PANVAX H1N1 VACCINE, H1N1 pandemic influenza vaccine (split-virion, inactivated) 0.5mL injection pre-filled syringe Australië - Engels - Department of Health (Therapeutic Goods Administration)

panvax h1n1 vaccine, h1n1 pandemic influenza vaccine (split-virion, inactivated) 0.5ml injection pre-filled syringe

seqirus pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: sodium chloride; dibasic sodium phosphate; monobasic sodium phosphate; potassium chloride; monobasic potassium phosphate; calcium chloride dihydrate - for active immunisation to prevent influenza disease caused by the influenza a (h1n1) virus, in persons from 6 months of age.

PANVAX H1N1 VACCINE, H1N1 pandemic influenza vaccine (split-virion, inactivated) 10mL multi-dose injection vial Australië - Engels - Department of Health (Therapeutic Goods Administration)

panvax h1n1 vaccine, h1n1 pandemic influenza vaccine (split-virion, inactivated) 10ml multi-dose injection vial

seqirus pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: sodium chloride; dibasic sodium phosphate; monobasic sodium phosphate; potassium chloride; monobasic potassium phosphate; calcium chloride dihydrate; thiomersal - for active immunisation to prevent influenza disease caused by the influenza a (h1n1) virus, in persons from 6 months of age.

PROTECH C4 + 2I Australië - Engels - APVMA (Australian Pesticides and Veterinary Medicines Authority)

protech c4 + 2i

boehringer ingelheim animal health australia pty. ltd. - canine parainfluenza; leptospira icterohaemorrhagiae antigen; canine adeno virus type 2; canine coronavirus vaccine - antigen; canine distemper virus; canine parvo virus - misc. vaccines or anti sera - canine parainfluenza vaccine active 0.0 undefined; leptospira icterohaemorrhagiae antigen vaccine-antigen active 0.0 undefined; canine adeno virus type 2 vaccine-viral active 0.0 undefined; canine coronavirus vaccine - antigen vaccine-viral active 0.0 undefined; canine distemper virus vaccine-viral active 0.0 undefined; canine parvo virus vaccine-viral active 0.0 undefined - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 1 | canine adenovirus - type 2 | canine coronavirus | canine distemper | canine parainfluenza | canine parvovirus | leptospira icterohaemorrhagiae | parvovirus

INACTIVATED INFLUENZA VACCINE 15/15/15mc %v/v Suspension for Injection Ierland - Engels - HPRA (Health Products Regulatory Authority)

inactivated influenza vaccine 15/15/15mc %v/v suspension for injection

sanofi pasteur msd ltd - a/california/7/2009 (h1n1)pdm09 - derived strain used nymc x-179a, a/hong kong/4801/2014 (h3n2) - like strain (a/hong kong/4801/2014, nymc x-263b), b/brisbane/60/2008 - like strain (b/brisbane/60/2008) - suspension for injection - 15/15/15mc %v/v - influenza vaccines

Fluad, Suspension for injection in pre-filled syringeInfluenza Vaccine, Surface Antigen, Inactivated, Adjuvanted with MF59C.1(20 Ierland - Engels - HPRA (Health Products Regulatory Authority)

fluad, suspension for injection in pre-filled syringeinfluenza vaccine, surface antigen, inactivated, adjuvanted with mf59c.1(20

seqirus s.r.l. - a/michigan/45/2015 (h1n1) pdm09 - like strain (a/singapore/gp1908/2015, ivr-180a); a/singapore/imfimh-16-0019/2016 (h3n2)-like strain (a/singapore/infimh-16-0019/2016,nib-104); b/colorado/06/2017-like strain (b/victoria/2/87 lineage)(b/maryland/15/2016,nymc bx-69a) - suspension for injection in pre-filled syringe - 0.5 millilitre(s) - influenza vaccines; influenza, inactivated, split virus or surface antigen - influenza vaccine - active immunisation against influenza in the elderly (65 years of age and over. refer to spc for detailed information.

INACTIVATED INFLUENZA VACCINE (SPLIT VIRION) BP, suspension for injection in prefilled syringe.Influenza vaccine (split virion, Ierland - Engels - HPRA (Health Products Regulatory Authority)

inactivated influenza vaccine (split virion) bp, suspension for injection in prefilled syringe.influenza vaccine (split virion,

sanofi pasteur - a/michigan/45/2015 (h1n1)pdm09 - like strain (a/michigan/45/2015, nymc x-275); a/hong kong/4801/2014 (h3n2) - like strain (a/hong kong/4801/2014, nymc x-263b); b/brisbane/60/2008 - like strain (b/brisbane/60/2008) - suspension for injection - 15/15/15mc percent volume/volume - influenza vaccines; influenza, inactivated, split virus or surface antigen